Century Therapeutics, Inc.
Century Therapeutics, Inc. (IPSC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ipsc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Century Therapeutics, Inc. (IPSC) measures how much investors pay for each dollar of the company's trailing earnings. IPSC's current PE ratio of N/A is calculated by dividing its stock price of $2.12 by its TTM earnings per share of -$1.25.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Century Therapeutics, Inc.You IPSC | $184M | N/A | — | -$1.25 |
 Coeptis Therapeutics, Inc. COEP | $58M | N/A | — | -$2.81 |
 Cue Biopharma, Inc. CUE | $76M | N/A | — | -$8.42 |
 Equillium, Inc. EQ | $98M | N/A | — | -$0.24 |
 Genenta Science S.p.A. GNTA | $34M | N/A | — | -$0.32 |
 Karyopharm Therapeutics Inc. KPTI | $193M | N/A | — | -$17.93 |
 Medicus Pharma Ltd. Common Stock MDCX | $7M | N/A | — | -$1.47 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.11 | — | |
2024-12-31 FY2024 | — | $-1.61 | — | |
2023-12-31 FY2023 | — | $-2.30 | — | |
2022-12-31 FY2022 | — | $-2.27 | — | |
2021-12-31 FY2021 | — | $-1.74 | — | |
2020-12-31 FY2020 | — | $-0.98 | — | |
2019-12-31 FY2019 | — | $-4.46 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Century Therapeutics, Inc. (IPSC) measures how much investors pay for each dollar of the company's trailing earnings. IPSC's current PE ratio of N/A is calculated by dividing its stock price of $2.12 by its TTM earnings per share of -$1.25.
Frequently asked questions
IPSC pe ratio · 6 questionsIPSC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $2.12 and TTM EPS of -$1.25. Data sourced from Financial Modeling Prep via IPSC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Century Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09